JP2024517801A5 - - Google Patents

Info

Publication number
JP2024517801A5
JP2024517801A5 JP2023567187A JP2023567187A JP2024517801A5 JP 2024517801 A5 JP2024517801 A5 JP 2024517801A5 JP 2023567187 A JP2023567187 A JP 2023567187A JP 2023567187 A JP2023567187 A JP 2023567187A JP 2024517801 A5 JP2024517801 A5 JP 2024517801A5
Authority
JP
Japan
Prior art keywords
formulation according
formulation
polysorbate
surfactant
etelcalcetide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023567187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/027451 external-priority patent/WO2022235654A1/en
Publication of JP2024517801A publication Critical patent/JP2024517801A/ja
Publication of JP2024517801A5 publication Critical patent/JP2024517801A5/ja
Pending legal-status Critical Current

Links

JP2023567187A 2021-05-06 2022-05-03 エテルカルセチド製剤 Pending JP2024517801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163184924P 2021-05-06 2021-05-06
US63/184,924 2021-05-06
PCT/US2022/027451 WO2022235654A1 (en) 2021-05-06 2022-05-03 Etelcalcetide formulations

Publications (2)

Publication Number Publication Date
JP2024517801A JP2024517801A (ja) 2024-04-23
JP2024517801A5 true JP2024517801A5 (https=) 2025-05-12

Family

ID=81750502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023567187A Pending JP2024517801A (ja) 2021-05-06 2022-05-03 エテルカルセチド製剤

Country Status (7)

Country Link
US (1) US20240207354A1 (https=)
EP (1) EP4333805A1 (https=)
JP (1) JP2024517801A (https=)
AU (1) AU2022268916A1 (https=)
CA (1) CA3218559A1 (https=)
MX (1) MX2023013066A (https=)
WO (1) WO2022235654A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
MX2012000100A (es) * 2009-07-01 2012-04-02 Fresenius Med Care Hldg Inc Dispositivos de suministro de farmaco y sistemas y metodos relacionados.
MA38724B1 (fr) 2013-06-28 2017-11-30 Amgen Inc Formulation liquide stable d'amg 416 (velcalcétide)
WO2021080822A1 (en) * 2019-10-24 2021-04-29 Amgen Inc. Systems and methods for drug delivery

Similar Documents

Publication Publication Date Title
JP2954356B2 (ja) 高分子4級アンモニウム化合物を含有する保存された眼科用薬剤組成物
US10039710B2 (en) Epinephrine spray formulations
JP6148317B2 (ja) 高眼圧症及び緑内障を治療するための方法及び組成物
HRP20110801T1 (hr) Tekući oblik fsh
JP2005537232A5 (https=)
JP2025114800A5 (https=)
JP2020516688A (ja) エピネフリンスプレー製剤
US9662334B2 (en) Sildenafil sublingual spray formulations
US20160243064A1 (en) Novel oral pharmaceutical compositions of treprostinil
ES2313670T3 (es) Suspension oftalmica que comprende un farmaco oftalmico, una polioxamina y un agente glicolico ajustador de la tonicidad, uso de dicha composicion para la fabricacion de un medicamento para tratar trstornos oftalmicos.
US10111833B2 (en) Sildenafil sublingual spray formulations
ES2197087T3 (es) Tabletas tragables con alto contenido de n-acetilcisteina.
WO2005013959A1 (en) Veterinary aqueous injectable suspensions containing florfenicol
JP2024517801A5 (https=)
JP2020105201A5 (https=)
JP2021520367A5 (https=)
JP2012140459A (ja) イソプロピルウノプロストンの分解抑制方法
JP2005531528A5 (https=)
PE20030970A1 (es) Formulacion de aerosol para inhalacion que contiene una sal de tiotropio
US20100215730A1 (en) Compositions for Nasal Administration of Phenothiazines
US20150140111A1 (en) Preparations of effervescent formulations comprising second and third generation cephalosporin and uses thereof
CN108601728A (zh) 包含局部用药物的盖仑制剂
CA3183290A1 (en) Tablet comprising opicapone
US12128054B2 (en) Aqueous pharmaceutical compositions of prostaglandins
ES2349410T3 (es) Formulación farmacéutica de agente de leucotrieno b4 (ltb4) estabilizado.